Biotech News

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Capricor Therapeutics (CAPR)Capricor Therapeutics2026-05-04 20:05 ESTEarnings

CAPR (CAPR) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is capr.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

CAPRCapricor Therapeutics2026-05-12 20:05 EST

Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

CAPRCapricor Therapeutics2026-03-09 12:30 EST

Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12

PTCTPTC Therapeutics, Inc.2026-05-07 20:01 EST

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

PTCTPTC Therapeutics, Inc.2026-04-22 12:00 EST

PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

ABEOAbeona Therapeutics2025-11-12 12:30 EST

Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates

MNPRMonopar2026-05-14 18:00 EST

Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

TARAProtara Therapeutics2026-05-13 12:00 EST

Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

MNPRMonopar2025-11-13 13:00 EST

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

ABEOAbeona Therapeutics2026-05-04 12:30 EST

Abeona Therapeutics® Announces Date of First Quarter Financial Results

TARAProtara Therapeutics2026-03-10 12:00 EST

Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

View all latest news

Capricor Therapeutics

Capricor Therapeutics is a cell-therapy company focused on rare disease and muscle disorders, especially Duchenne muscular dystrophy. Its platform centers on regenerative and immunomodulatory biology.

Recent company news

CAPRCapricor Therapeutics2026-07-27 15:00 EST

Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel

CAPRCapricor Therapeutics2026-06-26 14:02 EST

Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

CAPRCapricor Therapeutics2026-06-26 13:05 EST

Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference

CAPRCapricor Therapeutics2026-06-08 13:25 EST

Capricor Therapeutics to Present at Upcoming Investor Conferences

CAPRCapricor Therapeutics2026-05-29 01:55 EST

Capricor Therapeutics Expands Commercial Leadership Team

Stock data

Close: 7.00 USD
Market cap: 1.58B USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States